login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Fibrocell Science (FCSC) Stock News
NASDAQ:FCSC - Nasdaq -
3
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
FCSC Latest News, Press Relases and Analysis
All
Press Releases
5 years ago - By: Seeking Alpha
- Mentions:
RCAR
ABEO
KRYS
RenovaCare's SkinGun used in RDEB gene therapy study
6 years ago - By: WeissLaw LLP
SHAREHOLDER ALERT: WeissLaw LLP Investigates Fibrocell Science, Inc.
6 years ago - By: Rigrodsky & Long P.A.
FIBROCELL SCIENCE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
6 years ago - By: Analyst Ratings
What Made H.C. Wainwright Downgrade Fibrocell Science Inc’s Stock?
6 years ago - By: Halper Sadeh LLP
- Mentions:
VSI
MCRN
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - VSI, MCRN, FCSC
6 years ago - By: Zacks Investment Research
- Mentions:
ABBV
RETA
BGNE
Reata Successfully Completes Neuromuscular Disorder Study
6 years ago - By: Halper Sadeh LLP
- Mentions:
DOVA
SRCI
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - DOVA, SRCI, FCSC
6 years ago - By: Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Fibrocell Science, Inc. (NASDAQ: FCSC) on Behalf of Fibrocell Shareholders and Encourages Fibrocell Investors to Contact the Firm
6 years ago - By: Kahn Swick & Foti, LLC
FIBROCELL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fibrocell Science, Inc. - FCSC
6 years ago - By: Seeking Alpha
- Mentions:
ARQL
ESPR
GS
ACB
Stifel cuts view on Aurora Cannabis to Sell in premarket analyst action
6 years ago - By: Benzinga
- Mentions:
AXU
MCF
CNSL
DRAD
...
56 Biggest Movers From Friday
6 years ago - By: StockNews.com
- Mentions:
WINS
MCF
FRAN
NTEC
...
Best & Worst Performing Small Cap Stocks for September 14, 2019
6 years ago - By: Benzinga
- Mentions:
TGB
MTSL
GSM
PCYG
...
Mid-Afternoon Market Update: Park City Falls Following Q4 Results; MER Telemanagement Solutions Shares Climb
6 years ago - By: Seeking Alpha
- Mentions:
MTSL
FRAN
OPGN
VNCE
...
Microcaps mostly among midday movers
6 years ago - By: Seeking Alpha
- Mentions:
OPGN
ASLN
AUTL
DRAD
...
Healthcare - Top 5 Gainers / Losers
6 years ago - By: Seeking Alpha
- Mentions:
MTSL
CLRB
MNK
BITA
SDRL, MNK among premarket gainers
6 years ago - By: Seeking Alpha
Fibrocell up 64% premarket on Castle Creek bid
6 years ago - By: Castle Creek Pharmaceuticals
Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
6 years ago - By: Seeking Alpha
- Mentions:
KDMN
CRBP
GLPG
FDA OKs Boehringer Ingelheim's Ofev for rare lung disease
6 years ago - By: Analyst Ratings
- Mentions:
BPTH
Analysts Offer Insights on Healthcare Companies: Bio-Path Holdings (NASDAQ: BPTH) and Fibrocell Science Inc (NASDAQ: FCSC)
Please enable JavaScript to continue using this application.